583 related articles for article (PubMed ID: 32885754)
21. New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis.
Lupien A; Foo CS; Savina S; Vocat A; Piton J; Monakhova N; Benjak A; Lamprecht DA; Steyn AJC; Pethe K; Makarov VA; Cole ST
PLoS Pathog; 2020 Jan; 16(1):e1008270. PubMed ID: 31971990
[TBL] [Abstract][Full Text] [Related]
22. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs.
Paoli-Lombardo R; Primas N; Vanelle P
Eur J Med Chem; 2024 Aug; 274():116559. PubMed ID: 38850856
[TBL] [Abstract][Full Text] [Related]
23. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
[TBL] [Abstract][Full Text] [Related]
24. Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.
Gao C; Peng C; Shi Y; You X; Ran K; Xiong L; Ye TH; Zhang L; Wang N; Zhu Y; Liu K; Zuo W; Yu L; Wei Y
Sci Rep; 2016 Jul; 6():29717. PubMed ID: 27405961
[TBL] [Abstract][Full Text] [Related]
25. Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.
Lu XY; You QD; Chen YD
Mini Rev Med Chem; 2010 Mar; 10(3):181-92. PubMed ID: 20408801
[TBL] [Abstract][Full Text] [Related]
26. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
27. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.
Guardia A; Gulten G; Fernandez R; Gómez J; Wang F; Convery M; Blanco D; Martínez M; Pérez-Herrán E; Alonso M; Ortega F; Rullás J; Calvo D; Mata L; Young R; Sacchettini JC; Mendoza-Losana A; Remuiñán M; Ballell Pages L; Castro-Pichel J
ChemMedChem; 2016 Apr; 11(7):687-701. PubMed ID: 26934341
[TBL] [Abstract][Full Text] [Related]
28. Synthetic molecules as DprE1 inhibitors: A patent review.
Imran M; A S A; Thabet HK; Abida ; Afroz Bakht M
Expert Opin Ther Pat; 2021 Aug; 31(8):759-772. PubMed ID: 33709862
[TBL] [Abstract][Full Text] [Related]
29. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
30. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Doğan H; Doğan ŞD; Gündüz MG; Krishna VS; Lherbet C; Sriram D; Şahin O; Sarıpınar E
Eur J Med Chem; 2020 Feb; 188():112035. PubMed ID: 31951850
[TBL] [Abstract][Full Text] [Related]
31. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
[TBL] [Abstract][Full Text] [Related]
32. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
33. Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors.
Rogacki MK; Pitta E; Balabon O; Huss S; Lopez-Roman EM; Argyrou A; Blanco-Ruano D; Cacho M; Vande Velde CML; Augustyns K; Ballell L; Barros D; Bates RH; Cunningham F; Van der Veken P
J Med Chem; 2018 Dec; 61(24):11221-11249. PubMed ID: 30500189
[TBL] [Abstract][Full Text] [Related]
34. Trends in discovery of new drugs for tuberculosis therapy.
Riccardi G; Pasca MR
J Antibiot (Tokyo); 2014 Sep; 67(9):655-9. PubMed ID: 25095807
[TBL] [Abstract][Full Text] [Related]
35. Novel peptidomimetic peptide deformylase (PDF) inhibitors of Mycobacterium tuberculosis.
Gokhale KM; Telvekar VN
Chem Biol Drug Des; 2021 Jan; 97(1):148-156. PubMed ID: 32745362
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
37. Novel indolinone-tethered benzothiophenes as anti-tubercular agents against MDR/XDR M. tuberculosis: Design, synthesis, biological evaluation and in vivo pharmacokinetic study.
Eldehna WM; Mahmoud ST; Elshnawey ER; Elsayed ZM; Majrashi TA; El-Ashrey MK; Rashed M; Hemeda LR; Shoun AA; Elkaeed EB; El Hassab MA; Abdel-Aziz MM; Shahin MI
Bioorg Chem; 2024 Feb; 143():107009. PubMed ID: 38070474
[TBL] [Abstract][Full Text] [Related]
38. Identification of inhibitors against Mycobacterium tuberculosis thiamin phosphate synthase, an important target for the development of anti-TB drugs.
Khare G; Kar R; Tyagi AK
PLoS One; 2011; 6(7):e22441. PubMed ID: 21818324
[TBL] [Abstract][Full Text] [Related]
39. First triclosan-based macrocyclic inhibitors of InhA enzyme.
Rodriguez F; Saffon N; Sammartino JC; Degiacomi G; Pasca MR; Lherbet C
Bioorg Chem; 2020 Jan; 95():103498. PubMed ID: 31855823
[TBL] [Abstract][Full Text] [Related]
40. Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.
Campaniço A; Moreira R; Lopes F
Eur J Med Chem; 2018 Apr; 150():525-545. PubMed ID: 29549838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
